Endometriosis treatment spans a wide spectrum, from daily pills to complex surgery to newer approaches like neuromodulation and cognitive behavioral therapy. Because the condition is estrogen-driven and inflammatory, most first-line medical therapies work by lowering estrogen or counteracting its effects on displaced tissue. But no single treatment eliminates the disease for everyone, and the right approach depends heavily on whether the primary goal is pain relief, fertility, or both. The landscape has expanded considerably in recent years, and understanding the options gives you a much better shot at finding a combination that actually works for your situation.
Why Hormonal Therapy Is Usually the Starting Point
Endometriosis affects roughly one in ten women of reproductive age, and the displaced endometrial-like tissue that characterizes it responds to the same hormonal signals as the uterine lining itself.1PubMed Central. Contraception and endometriosis: challenges, efficacy, and therapeutic importance Estrogen fuels the growth and inflammation of these lesions, so the core strategy of most medical treatments is to reduce estrogen levels or block its activity at the tissue level. At the same time, endometriotic tissue shows resistance to progesterone, a hormone that normally keeps the endometrium in check. This dual hormonal imbalance, excess estrogen activity and inadequate progesterone response, drives the proliferation, inflammation, and pain that define the disease.2PubMed. Hormonal therapy for endometriosis: from molecular research to bedside
The most commonly prescribed hormonal treatments include combined oral contraceptives (the standard birth control pill), progestin-only pills, and progestin-releasing intrauterine devices. These work through slightly different mechanisms but share a common thread: they suppress ovulation, thin the endometrial tissue, or both. For many people, continuous use of hormonal contraceptives, skipping the placebo week to avoid withdrawal bleeding altogether, provides meaningful pain relief.
Progestins and the Levonorgestrel IUD
Progestins deserve special attention because they address the progesterone-resistance problem more directly than combined pills. Dienogest is one of the most studied progestins for endometriosis and is specifically approved for it in many countries. Medroxyprogesterone acetate and norethindrone acetate are older options that remain widely used. These drugs thin the endometrial-like tissue, reduce inflammation, and often induce lighter periods or no periods at all.
The levonorgestrel-releasing intrauterine device offers a localized alternative. It delivers a small amount of progestin directly into the uterine cavity each day, which means systemic side effects tend to be milder than with oral progestins.3PubMed Central. Hormonal treatment for endometriosis associated pelvic pain Research has shown that it reduces period pain, chronic pelvic pain, and pain during sex, and can even shrink endometriotic lesions in some cases.4PubMed. Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis The IUD is often a good fit for people who want long-term suppression without remembering a daily pill, though it does not work equally well for all types of endometriosis, particularly deep disease outside the pelvic cavity.
GnRH Agonists and Antagonists
When first-line hormonal treatments fall short, the next step often involves drugs that act on the brain’s hormonal control center. GnRH agonists (like leuprolide) have been used for decades. They initially cause a surge in reproductive hormones before shutting them down, ultimately putting the body into a temporary menopause-like state. This drops estrogen levels dramatically and starves endometriotic tissue of its fuel. The downside: hot flashes, vaginal dryness, mood changes, and bone density loss, side effects that can be significant.
Oral GnRH antagonists represent a newer class that has changed the treatment picture. Rather than the agonist’s initial hormone surge, antagonists block the receptors directly and suppress estrogen quickly.5PubMed Central. Oral Gonadotropin-Releasing Hormone Antagonists in the Treatment of Endometriosis: Advances in Research Elagolix was the first oral GnRH antagonist approved specifically for endometriosis-related pain, followed by relugolix (in combination with estradiol and norethindrone). These pills allow dose adjustments that are harder to achieve with injectable agonists.
A key innovation with these newer antagonists is “add-back therapy,” meaning small doses of estrogen and progestin given alongside the GnRH antagonist. The idea is to keep estrogen low enough to suppress endometriosis but high enough to protect bone and ease menopausal symptoms. Data from a phase 3 trial showed that patients taking elagolix with add-back therapy had less than one percent change in bone mineral density at both six and twelve months, a reassuring signal for longer-term use.6PubMed. Efficacy, tolerability, and bone density outcomes of elagolix with add-back therapy for endometriosis-associated pain: twelve months of an ongoing randomized phase 3 trial Without add-back, bone loss can become clinically meaningful within months, which is why current guidelines generally recommend pairing the two.
When Surgery Makes Sense
Surgery enters the picture when medical therapy fails to control pain, when imaging reveals deep or extensive disease, or when fertility is the primary goal. The vast majority of endometriosis surgery today is performed laparoscopically, through small incisions, rather than through a large open procedure. But within laparoscopic surgery, there is an important distinction between excision and ablation.
Excision means cutting out the endometriotic lesion entirely, including the tissue beneath the surface. Ablation means burning or vaporizing the visible surface of the lesion. A meta-analysis comparing the two found that excision produced a greater reduction in period pain, pain with bowel movements, and chronic pelvic pain compared to ablation at twelve months after surgery.7PubMed. Laparoscopic Excision Versus Ablation for Endometriosis-associated Pain: An Updated Systematic Review and Meta-analysis The advantage was particularly clear for chronic pelvic pain and quality-of-life scores.850 Studies Every Obstetrician-Gynecologist Should Know. Laparoscopic Excision Versus Ablation for Endometriosis-Associated Pain The logic makes sense: ablation may leave deeper disease behind, which continues to cause symptoms.
This doesn’t mean ablation is always wrong. In early-stage, superficial endometriosis, ablation can be effective and faster to perform. But for deep infiltrating endometriosis, most specialist surgeons favor excision. Finding a surgeon with specific expertise in endometriosis excision matters, since outcomes vary substantially with surgical skill.
Complex and Deep Disease
Endometriosis doesn’t always stay on the surface of pelvic organs. It can infiltrate the bowel wall, the bladder, the ureters, and the ligaments deep in the pelvis. When it involves the bowel, the surgical approach gets more complicated and often requires a multidisciplinary team that includes a colorectal surgeon. Depending on the size and location of the lesion, the surgeon may perform a disc excision (removing a small area of the bowel wall) or a segmental bowel resection (removing a section of bowel and reconnecting it). Long-term outcomes after bowel resection for severe endometriosis are generally good in terms of pain relief, and about half of those wanting pregnancy go on to conceive afterward.9PubMed Central. Bowel endometriosis: colorectal surgeon’s perspective in a multidisciplinary surgical team
These complex surgeries carry higher risks than standard laparoscopic excision, including potential complications like anastomotic leak, fistula formation, or temporary bowel dysfunction. This is why referral to a specialized center with experience in advanced endometriosis surgery is so important when deep disease is suspected.
Hysterectomy and Its Limitations
Hysterectomy, sometimes with removal of the ovaries, is often presented as a definitive treatment. It can be profoundly effective for adenomyosis (a related condition where endometrial tissue grows within the muscle of the uterus itself) and for reducing symptoms related to the uterus. But for endometriosis specifically, hysterectomy alone does not guarantee a cure, and this is one of the most important misconceptions to correct.
If endometriotic lesions elsewhere in the pelvis are left behind during hysterectomy, symptoms often persist. Research has found that in cases where the uterus and ovaries were removed but deep lesions on structures like the uterosacral ligaments or bowel were left in place, the remaining disease continued to cause pain. In many of these cases, the disease was visible at the time of surgery but simply was not treated.10PubMed Central. Recurrence of endometriosis after hysterectomy The takeaway: if hysterectomy is on the table, thorough excision of all visible endometriosis at the same time is critical. Removing the uterus while leaving disease behind is treating the wrong target.
There’s also the question of hormone replacement therapy (HRT) after surgical menopause. Women who have their ovaries removed before natural menopause typically need HRT for bone and cardiovascular health. But because endometriosis is estrogen-driven, HRT can occasionally reactivate residual disease. Molecular studies have found that endometriotic lesions overexpress certain estrogen receptors at levels far higher than normal endometrial tissue, which may explain why even small amounts of estrogen replacement can fuel progression in some cases.11PubMed Central. HRT in Women Undergoing Pelvic Clearance for Endometriosis—A Case Report and a National Survey This does not mean HRT is always contraindicated after surgery for endometriosis, but it does mean the decision requires careful individualized discussion.
Fertility and Endometriosis
Here is where treatment goals can directly conflict. The hormonal therapies that suppress endometriosis also suppress ovulation, meaning they prevent pregnancy while you’re on them. And the evidence is clear that suppressive medical treatment of endometriosis does not improve fertility and should not be used for that purpose alone.12PubMed. Endometriosis and infertility: epidemiology and evidence-based treatments Surgery, on the other hand, can improve fertility across all stages of the disease by removing the physical barriers and inflammatory environment that impair conception.
For those who don’t conceive after surgery, or who have advanced disease, assisted reproductive technology like IVF becomes the next step. IVF can bypass many of the mechanisms through which endometriosis impairs fertility, including tubal damage, ovulation problems, and fertilization failure. However, success rates are somewhat lower for people with advanced-stage endometriosis. One meta-analysis reported a decreased odds of live birth in women with stage III-IV disease compared to other causes of infertility.13PubMed Central. Endometriosis and IVF treatment outcomes: unpacking the process Still, IVF remains one of the most effective fertility treatments available for this population.
The Pain Problem Beyond Lesions
One of the most frustrating aspects of endometriosis is that removing all visible disease doesn’t always eliminate pain. This happens because chronic pain changes the nervous system itself. Endometriotic lesions stimulate abnormal nerve fiber growth and sustained inflammatory signaling. Over time, the spinal cord and brain begin amplifying pain signals, a process called central sensitization. The nervous system essentially learns to overreact, so that stimuli that wouldn’t normally be painful become intensely so.14PubMed Central. Research on central sensitization of endometriosis-associated pain: a systematic review of the literature
This is why some people continue to have pain after what appears to be a technically successful surgery. The disease may be gone, but the pain circuitry remains rewired. Recognizing this isn’t about dismissing anyone’s pain as “in their head.” It’s the opposite: the nervous system changes are measurable and physical. But they do require different treatment strategies than hormones or scalpels can provide.
Physical Therapy and Neuromodulation
Chronic pelvic pain from endometriosis often coexists with pelvic floor dysfunction. The muscles of the pelvic floor can become chronically tense and hypersensitive in response to years of pain, creating a secondary source of discomfort that persists independently of the endometriosis itself. Pelvic floor physiotherapy aims to address this by working on muscle relaxation, trigger points, and movement patterns.15PubMed. Assessment of levator hiatal area using 3D/4D transperineal ultrasound in women with deep infiltrating endometriosis and superficial dyspareunia treated with pelvic floor muscle physiotherapy: randomized controlled trial Multimodal protocols that combine physiotherapy with other treatments after surgical excision have shown promise for tackling the residual sensitization and muscular pain that surgery alone doesn’t resolve.16PubMed Central. A Comprehensive Treatment Protocol for Endometriosis Patients Decreases Pain and Improves Function
Transcutaneous electrical nerve stimulation (TENS) is another non-invasive option gaining attention. A randomized controlled trial found that TENS significantly improved chronic pelvic pain, pain during sex, and quality of life in women with deep endometriosis.17PubMed. Effectiveness of complementary pain treatment for women with deep endometriosis through Transcutaneous Electrical Nerve Stimulation (TENS): randomized controlled trial The device works by delivering mild electrical impulses through skin electrodes, which may interrupt pain signaling. It’s inexpensive, portable, and has essentially no serious side effects, making it a useful add-on even if it’s not a standalone solution for most people.
Cognitive Behavioral Therapy
The psychological burden of endometriosis is substantial, and it’s not just a secondary inconvenience. Depression, anxiety, and chronic stress are common, and they actively worsen pain perception through the same central sensitization pathways already discussed. Cognitive behavioral therapy has shown measurable benefits for people with endometriosis. A systematic review found that CBT techniques decreased pain sensation, improved depression and stress scores, and led to meaningful changes in quality of life, including physical functioning, social engagement, and emotional well-being.18PubMed Central. Cognitive Behavioral Therapy in Endometriosis, Psychological Based Intervention: A Systematic Review
A randomized trial specifically testing CBT in women with endometriosis and chronic pelvic pain confirmed these findings, showing improvements across depression, stress, quality of life, pain perception, and emotional distress in the intervention group compared to controls.19PubMed. Efficacy of Cognitive Behavioral Therapy in treating women with endometriosis and chronic pelvic pain: A randomized trial CBT doesn’t treat the lesions themselves, but by reshaping how the brain processes pain and emotional distress, it can genuinely reduce the lived experience of the disease. It’s most useful as part of a broader plan rather than as a replacement for medical or surgical treatment.
Treating Endometriosis in Adolescents
Endometriosis can begin in the teenage years, and delayed diagnosis is a longstanding problem. Severe period pain in adolescents is often dismissed as normal, leading to years of untreated disease. The treatment approach in teens follows a similar ladder to adults but with some age-specific considerations. Anti-inflammatory medications like ibuprofen are the first step. If those aren’t enough, hormonal options including combined contraceptives and progestin-only methods are considered safe and effective for adolescents. For more severe cases, GnRH agonists with add-back therapy can be used. If surgery is performed and endometriosis is found, either excision or ablation is appropriate.20PubMed Central. Dysmenorrhea, Endometriosis and Chronic Pelvic Pain in Adolescents
One important point for younger patients: counseling about long-term menstrual suppression is recommended until fertility is desired. This isn’t about masking symptoms. Continuous suppression limits the repeated hormonal cycling that drives disease progression. Early treatment may also help prevent the nervous system changes that make pain harder to treat later.
Dietary Approaches and Supplements
Many people with endometriosis experiment with dietary changes, and the interest is understandable given the limited options. A systematic review of studies on nutrients and endometriosis symptoms found that supplemental fatty acids, antioxidants, and certain vitamin-mineral combinations may have a positive effect on symptoms.21Reproductive BioMedicine Online. The effects of nutrients on symptoms in women with endometriosis: a systematic review The emphasis here is on “may”: the evidence base is thin, with few high-quality trials and little consensus on which specific nutrients matter or at what doses. Anti-inflammatory dietary patterns (broadly, diets rich in vegetables, fish, and whole grains while low in red meat and processed food) are often recommended by clinicians, though this advice rests more on general inflammatory disease logic than on endometriosis-specific proof.
Dietary changes are reasonable as a complement to proven treatments but unreliable as a primary strategy. No diet has been shown to shrink endometriotic lesions or replace medical or surgical therapy.
What’s in the Research Pipeline
The limits of current hormonal therapy are clear: it suppresses the disease but doesn’t cure it, it prevents pregnancy while you’re on it, and side effects push many people to stop treatment. This has spurred research into non-hormonal approaches that target the molecular and immune mechanisms driving endometriosis. Areas of active investigation include drugs that block angiogenesis (the growth of new blood vessels that feed lesions), anti-inflammatory agents targeting specific immune pathways, and therapies based on newly discovered biomarkers that could allow more precise targeting of endometriotic tissue without affecting the whole body.22PubMed Central. Non-Hormonal Strategies in Endometriosis: Targets with Future Clinical Potential
Aromatase inhibitors, drugs that block the enzyme responsible for estrogen production within the endometriotic tissue itself, represent another frontier. Originally developed for breast cancer, these have been explored for endometriosis that resists standard hormonal treatment.23PubMed. Treatment of severe postmenopausal endometriosis with an aromatase inhibitor They are not yet mainstream for endometriosis and carry their own side effects, including bone density concerns, but they illustrate the direction the field is moving: toward treatments that act locally at the lesion rather than globally suppressing the hormonal system.
None of these pipeline therapies are likely to arrive as magic bullets. Endometriosis is a disease of displaced tissue, abnormal immune responses, altered hormonal signaling, and nervous system rewiring all at once. The most effective treatment strategies today already reflect that complexity, combining surgery for the tissue, hormones for the environment, physical therapy for the muscles, and psychological support for the pain system. The future is likely more of that layered approach, just with more precise tools at each level.